Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test ratios may offer cheaper way to track colitis

NCT ID NCT07261579

Diagnosis Sponsor: Benha University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether simple blood test ratios, like CRP-to-albumin, can help monitor disease activity in people with ulcerative colitis. Researchers compared these blood markers to standard colonoscopy and symptom scores in 80 patients. The goal was to find a less invasive, cost-effective way to track inflammation and disease severity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
C-Reactive Protein (CRP) and related blood test ratios
What this could lead to
If successful, this could lead to a simpler, cheaper way to monitor ulcerative colitis severity using routine blood tests instead of invasive colonoscopies.
What could go wrong
This is a small, completed study (80 people) that only looked at correlations, not a treatment. The findings may not apply to all patients or replace standard monitoring methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

80 people

The number who actually took part.

Started

Sep 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consisted of all patients exhibiting clinical signs suggestive of Inflammatory Bowel Disease were assessed for Ulcerative Colitis diagnostic criteria.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who fulfilled the diagnostic criteria for UC; * Patients were free of exclusion criteria; * Patients who signed the written consent were enrolled in the study Exclusion Criteria: * Patients who was Previously diagnosed with IBD or IBS; * Patients with recurrence of manifestations after surgical resection; * Patients who refused to sign the participation consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ulcerative colitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ulcerative colitis

Contacts and locations

Locations

  • Alexandria Faculty of medicine

    Alexandria, El Alexandria, 21512, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.